Nikhil Pahelkar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Nikhil Pahelkar has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Abhishek B. Suryawanshi
Department of Biosciences and Bioengineering Indian Institute of Technology Bombay Mumbai India
2 shared publications Alla Gustchina
Protein Structure Section, Center for Structural Biology National Cancer Institute Frederick Maryland USA
2 shared publications- Anuradha Deshmukh
Department of Biosciences and Bioengineering Indian Institute of Technology Bombay Mumbai India
2 shared publications Huogen Xiao
Summerland Research and Development Center Agriculture and Agri‐Food Canada Summerland British Columbia Canada
2 shared publications- Ishan Rathore
Center for Structural Biology, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA
2 shared publications Jan Abendroth
UCB Pharma Bainbridge Island Washington USA
2 shared publications
Latest Publications
- Open Access
- 30 December 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (2) , 108152
A physicochemical rationale for the varied catalytic efficiency in RNase J paralogues
- 30 December 2024
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 301 (2) , 108152
Open AccessA physicochemical rationale for the varied catalytic efficiency in RNase J paralogues
- 20 January 2022
- Published by Wiley in Protein Science
- Vol. 31 (4) , 882-899
Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme
Plasmodium falciparum plasmepsin X (PfPMX), involved in the invasion and egress of this deadliest malarial parasite, is essential for its survival and hence considered as an important drug target. We report the first crystal structure of PfPMX zymogen containing a novel fold of its prosegment. A unique twisted loop from the prosegment and arginine 244 from the mature enzyme is involved in zymogen inactivation; such mechanism, not previously reported, might be common for apicomplexan proteases similar to PfPMX. The maturation of PfPMX zymogen occurs through cleavage of its prosegment at multiple sites. Our data provide thorough insights into the mode of binding of a substrate and a potent inhibitor 49c to PfPMX. We present molecular details of inactivation, maturation, and inhibition of PfPMX that should aid in the development of potent inhibitors against pepsin‐like aspartic proteases from apicomplexan parasites.
- 20 January 2022
- Published by Wiley in Protein Science
- Vol. 31 (4) , 882-899
Structures of plasmepsin X from Plasmodium falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme
Plasmodium falciparum plasmepsin X (PfPMX), involved in the invasion and egress of this deadliest malarial parasite, is essential for its survival and hence considered as an important drug target. We report the first crystal structure of PfPMX zymogen containing a novel fold of its prosegment. A unique twisted loop from the prosegment and arginine 244 from the mature enzyme is involved in zymogen inactivation; such mechanism, not previously reported, might be common for apicomplexan proteases similar to PfPMX. The maturation of PfPMX zymogen occurs through cleavage of its prosegment at multiple sites. Our data provide thorough insights into the mode of binding of a substrate and a potent inhibitor 49c to PfPMX. We present molecular details of inactivation, maturation, and inhibition of PfPMX that should aid in the development of potent inhibitors against pepsin‐like aspartic proteases from apicomplexan parasites.
- Open Access
Structures of plasmepsin X from P. falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme
Plasmodium falciparum plasmepsin X ( Pf PMX), involved in the invasion and egress of this deadliest malarial parasite, is essential for its survival and hence considered as an important drug target. We report the first crystal structure of Pf PMX zymogen containing a novel fold of its prosegment. A unique twisted loop from the prosegment and arginine 244 from the mature enzyme are involved in zymogen inactivation; such mechanism, not previously reported, might be common for apicomplexan proteases similar to Pf PMX. The maturation of Pf PMX zymogen occurs through cleavage of its prosegment at multiple sites. Our data provide thorough insights into the mode of binding of a substrate and a potent inhibitor 49c to Pf PMX. We present molecular details of inactivation, maturation, and inhibition of Pf PMX that should aid in the development of potent inhibitors against pepsin-like aspartic proteases from apicomplexan parasites.
Open AccessStructures of plasmepsin X from P. falciparum reveal a novel inactivation mechanism of the zymogen and molecular basis for binding of inhibitors in mature enzyme
Plasmodium falciparum plasmepsin X ( Pf PMX), involved in the invasion and egress of this deadliest malarial parasite, is essential for its survival and hence considered as an important drug target. We report the first crystal structure of Pf PMX zymogen containing a novel fold of its prosegment. A unique twisted loop from the prosegment and arginine 244 from the mature enzyme are involved in zymogen inactivation; such mechanism, not previously reported, might be common for apicomplexan proteases similar to Pf PMX. The maturation of Pf PMX zymogen occurs through cleavage of its prosegment at multiple sites. Our data provide thorough insights into the mode of binding of a substrate and a potent inhibitor 49c to Pf PMX. We present molecular details of inactivation, maturation, and inhibition of Pf PMX that should aid in the development of potent inhibitors against pepsin-like aspartic proteases from apicomplexan parasites.